# France’s biotech ecosystem: science, capital and scale Page: https://stenobird.com/podcast/biospace-6696251/france-s-biotech-ecosystem-science-capital-and-scale Text version: https://stenobird.com/podcast/biospace-6696251/france-s-biotech-ecosystem-science-capital-and-scale.md Podcast: [BioSpace](https://stenobird.com/podcast/biospace-6696251) Published: 2026-05-28T07:00:00+00:00 Episode link: https://api.riverside.com/hosting-analytics/media/78432452d425c03a67089fed6cc1beb4049361ea17549188bdb0141243930ef5/eyJlcGlzb2RlSWQiOiJmMzI3NTAyZC0yZDA5LTRiNGQtYTM1Zi0xYTJhOWM0ODQxOWMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmExNmI4YTk4M2Q0MGQ1NWRmYjg0MjczL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTI3X18xMS0yNi0xLm1wMyJ9.mp3 Audio file: https://api.riverside.com/hosting-analytics/media/78432452d425c03a67089fed6cc1beb4049361ea17549188bdb0141243930ef5/eyJlcGlzb2RlSWQiOiJmMzI3NTAyZC0yZDA5LTRiNGQtYTM1Zi0xYTJhOWM0ODQxOWMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmExNmI4YTk4M2Q0MGQ1NWRmYjg0MjczL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTI3X18xMS0yNi0xLm1wMyJ9.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/france-s-biotech-ecosystem-science-capital-and-scale Duration seconds: 1260 ## Resource In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, managing partner at Kurma Partners. We dive into France’s biotech ecosystem and what still needs to happen for more early innovation to translate into investable, scalable biotech. Host ⁠Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Ksenija Pavletic , Partner and Chief Commercial Officer, Jeito Capital Thierry Laugel , Managing Partner, Kurma Partners Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations. ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/france-s-biotech-ecosystem-science-capital-and-scale/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/biospace-6696251/france-s-biotech-ecosystem-science-capital-and-scale.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.